Sue Gibbons, MSN

Kiniksa
Emerson, NJ, United States

Sr. Medical Science Liaison, Kiniksa Pharmaceuticals

Presentation(s):

• 1186: Increased Adoption of IL-1 Pathway Inhibition and the Steroid-sparing Paradigm Shift: Temporal Trends in Recurrent Pericarditis Treatment From the RESONANCE Patient Registry

  Monday, October 27, 2025
  10:30 AM - 12:30 PM Central Time

  Disclosure(s): Kiniksa Pharmaceuticals: Employee (Ongoing)